Novartis AG (NVSEF)

Novartis AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 3, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	295,041	265,212	195,695	207,167	194,448	197,007
Market Cap Growth	49.76%	35.52%	-5.54%	6.54%	-1.30%	-8.39%
Enterprise Value	319,921	288,115	212,877	220,692	204,644	224,014
Last Close Price	152.77	138.00	92.92	96.69	84.10	80.09
PE Ratio	21.10	18.97	16.39	13.95	27.96	8.20
PS Ratio	5.21	4.68	3.78	4.44	4.47	4.48
PB Ratio	6.34	5.70	4.43	4.43	3.27	2.91
P/TBV Ratio	-	-	-	-	-	21.01
P/FCF Ratio	16.77	15.07	12.04	15.46	14.60	14.07
P/OCF Ratio	15.41	13.85	11.11	14.33	13.66	13.07
EV/Sales Ratio	5.52	5.08	4.12	4.73	4.71	5.09
EV/EBITDA Ratio	13.19	12.27	10.30	12.15	14.68	14.33
EV/EBIT Ratio	16.48	15.16	13.04	21.57	22.21	20.43
EV/FCF Ratio	18.18	16.37	13.10	16.47	15.36	16.00
Debt / Equity Ratio	0.76	0.76	0.71	0.57	0.47	0.46
Debt / EBITDA Ratio	1.49	1.49	1.50	1.44	1.97	1.95
Debt / FCF Ratio	2.02	2.02	1.93	1.97	2.10	2.22
Asset Turnover	0.53	0.53	0.51	0.43	0.35	0.34
Inventory Turnover	2.27	2.27	2.20	1.91	1.67	1.65
Quick Ratio	0.82	0.82	0.78	0.88	1.00	1.25
Current Ratio	1.12	1.12	1.03	1.16	1.29	1.51
Return on Equity (ROE)	30.81%	30.81%	26.27%	16.15%	9.51%	36.80%
Return on Assets (ROA)	11.14%	11.14%	10.09%	5.88%	4.62%	5.28%
Return on Invested Capital (ROIC)	23.60%	24.47%	23.55%	15.05%	11.14%	13.29%
Return on Capital Employed (ROCE)	22.70%	22.70%	22.20%	13.90%	10.40%	10.80%
Earnings Yield	4.74%	5.27%	6.10%	7.17%	3.58%	12.19%
FCF Yield	5.96%	6.64%	8.30%	6.47%	6.85%	7.11%
Dividend Yield	2.60%	3.38%	4.16%	4.05%	4.12%	4.25%
Payout Ratio	55.91%	55.91%	63.85%	48.85%	107.92%	30.67%
Buyback Yield / Dilution	3.93%	3.93%	2.73%	4.78%	2.79%	1.57%
Total Shareholder Return	6.53%	7.31%	6.88%	8.83%	6.90%	5.81%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.